Wen-Han Feng
Publications by Year
Research Areas
Antiplatelet Therapy and Cardiovascular Diseases, Coronary Interventions and Diagnostics, Atrial Fibrillation Management and Outcomes, Acute Myocardial Infarction Research, Cardiac Fibrosis and Remodeling
Most-Cited Works
- → Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample(2016)280 cited
- → Effects of Lipids and Lipoproteins on Mesenchymal Stem Cells Used in Cardiac Tissue Regeneration(2020)22 cited
- → P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention(2020)10 cited
- → A three-step stacking capillary electrophoresis of field-amplified sample injection, sweeping, and micellar collapse for determination of dabigatran and its active metabolite in human plasma(2022)9 cited
- → Tumor endothelial marker 1 is upregulated in heart after cardiac injury and participates in cardiac remodeling(2022)8 cited
- → P2Y12 Inhibitor Monotherapy versus Conventional Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Meta-Analysis(2023)8 cited
- → Fulminant myocarditis complicated with obstructive ST-elevation myocardial infarction—a rare case report(2013)6 cited
- → Soluble tumor endothelial marker 1 in heart failure with reduced ejection fraction: A pilot study(2022)6 cited
- → Comparative Efficacy and Safety of P2Y12 Inhibitor Monotherapy and Dual Antiplatelet Therapy in Patients with and without Diabetes Mellitus Undergoing Percutaneous Coronary Intervention(2022)4 cited
- → The effects of secondary prevention after coronary revascularization in Taiwan(2019)4 cited